Abhishek Pal, a rising star in Indian athletics who secured his place in the upcoming Asian Games by meeting the qualifying standards in both the 5,000‑metre and 10,000‑metre races, was notified on Monday that an out‑of‑competition sample had tested positive for clomiphene, a substance listed under the World Anti‑Doping Agency's (WADA) prohibited list. The National Anti‑Doping Agency (NADA) in India has placed Pal under a provisional suspension pending a formal hearing, effectively barring him from competing in the Games unless the decision is overturned. Pal, who hails from Haryana and has been a regular fixture in national championships, has publicly stated his intention to contest the finding, asserting that he had no knowledge of ingesting the drug and that the result may stem from a contaminated supplement. His legal team is expected to file an appeal within the stipulated 14‑day window, seeking a re‑analysis of the sample and a review of the chain‑of‑custody procedures.
The provisional ban comes at a critical juncture for India's athletics contingent, which is finalising its squad for the Asian Games slated to begin in Hangzhou later this month. If Pal's appeal fails, the Indian Olympic Association will have to nominate an alternate athlete for the long‑distance events, potentially reshaping the team's medal prospects. NADA officials have reiterated that the anti‑doping code applies uniformly, and any athlete found with a prohibited substance faces immediate suspension, regardless of their stature or upcoming competitions. The case underscores the stringent compliance measures that Indian athletes must observe ahead of major international meets.
ALSO READ | Ben Shelton and Trinity Rodman lean on each other as they chase US Open glory
